These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21105573)

  • 1. Preparation and in vivo evaluation of thienorphine-loaded PLGA microspheres.
    Yang Y; Gao Y
    Pharmazie; 2010 Oct; 65(10):729-32. PubMed ID: 21105573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
    Yang Y; Gao Y; Mei X
    Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gamma-irradiation on PLGA microspheres loaded with thienorphine.
    Yang Y; Gao Y; Mei X
    Pharmazie; 2011 Sep; 66(9):694-7. PubMed ID: 22026126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
    Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and biodistribution of paclitaxel-loaded microspheres.
    Yan F; Tang S; Fu Q
    Arzneimittelforschung; 2012 Apr; 62(4):176-80. PubMed ID: 22270845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
    Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y
    Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres.
    Seo SA; Khang G; Rhee JM; Kim J; Lee HB
    J Microencapsul; 2003; 20(5):569-79. PubMed ID: 12909542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
    Radwan MA; Aboul-Enein HY
    Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs.
    Chu DF; Fu XQ; Liu WH; Liu K; Li YX
    Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT; Tao XM; Mo W; Song HY
    Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
    Uchida T; Yagi A; Oda Y; Goto S
    J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
    Pinto E; Zhang B; Song S; Bodor N; Buchwald P; Hochhaus G
    Pharmazie; 2010 Jun; 65(6):429-35. PubMed ID: 20614691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.